Dave Weiner

Biography

 Dave Weiner is Chief Medical Officer of Lumos Pharma. Dr. Weiner has over 20 years of experience in the discovery and clinical development of novel therapeutics for neurological disease.  He started his career at ACADIA Pharmaceuticals, where, over a ten-year period, he held a series of discovery research and clinical development roles working on multiple CNS therapeutics, most notably Pimavanserin.  He subsequently joined EMD Serono, in a late clinical development role, and ultimately heading early clinical development activities in neurology globally.  Dave has extensive experience in rare disease drug development, serving as CMO and Interim CEO for Proteostasis Therapeutics Inc., and most recently as CMO at aTYR Pharma, Inc.  

Research Interest

Molecular Biology